What happened
Anthropic launched Claude for Life Sciences, an AI tool designed to support researchers throughout the drug discovery process. The system integrates with popular scientific platforms like Benchling, 10x Genomics, and PubMed to streamline data access and analysis. Claude Sonnet 4.5, the latest model, shows improved performance on life sciences tasks compared to previous versions.
Why it matters
- Claude for Life Sciences aims to accelerate scientific progress in drug discovery by improving research efficiency.
- Integration with established lab tools reduces the need for manual data handling, enhancing workflow continuity.
- Improved AI capabilities may help life sciences organizations with regulatory submissions and complex bioinformatics analysis.
Key facts
- 1. Claude Sonnet 4.5 scored 0.83 on the Protocol QA benchmark, surpassing the human baseline of 0.79 and the previous Sonnet 4 score of 0.74.
- 2. The announcement was made approximately three weeks ago, in late October 2025.
- 3. Anthropic has partnered with consulting firms such as Deloitte, KPMG, and Caylent to support adoption in life sciences organizations.
